Clinical Trials Articles
EU Agencies Update
Responsibility for pharmaceuticals in the European Union is divided between the governments of the 27 member states* and the EU's institutions. The principal EU bodies concerned are the European Commission in Brussels and the European Medicines Agency in London.
U.S. Departments and Offices
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office for Human Research Protection
Director
NIH Institutes, Center, and Divisions
Jerry Menikoff (240) 453-6900
Deputy Director and Director, Office of International Activities
Melody Lin (240) 453-8126
Associate Director, Regulatory Affairs
Michael Carome (240) 453-8237
Director, Division of Compliance Oversight
Business and People Update
Ravi Pawa
Bringing with her over 15 years of clinical and research experience, Ravi Pawa, MB ChB, is Synexus' (Lancashire, UK) new medical advisor. Pawa previously served as the company's clinical director of the Lancashire Research Center.
David Tousley
Work-Life Notes from a Large CRO
Work-Life Notes from a Large CRO
Nov 1, 2008
By: Lisa Henderson
Applied Clinical Trials
Work-Life Notes from the FDA
Work-Life Notes from the FDA
Nov 1, 2008
By: Marissa Shapiro
Applied Clinical Trials
2008 Salary and Satisfaction Survey of Clinical Research Professionals
Related Articles
2006 Survey of Wages and Job Trends in the Clinical Trials Industry
- 4 comments
- Read more
- 307 reads
Balancing Perceptions of Risk in Clinical Research
The public's misperception of risk is one of the most important places to begin to educate the public and restore trust and confidence. The public believes largely that drugs should be free from side effects. This naïve and misinformed perception crosses over into the public's view of clinical research.
Europe Reviews Balance of Interests
New legislation on the use of animals in experimentation looms ever larger in Europe, as officials in Brussels squabble over the final draft of a proposal to update the rules in place now for more than 20 years. There are strong pressures from animal protection groups in Europe for stricter regulation.
The Critical Path Comes of Age at FDA
After four years of laying a foundation for new efforts to streamline clinical testing and drug development, leaders of the Food and Drug Administration are poised to move the agency's Critical Path Initiative (CPI) from concept to implementation.
eClinical Software
Send your new product info to: Kerri Nelen, knelen@advanstar.com
Enterprise Document Management for the Lab
NextDocs integrated document solution
Collaborative agreement calls for product bundle for laboratories
